Pricing Log in Create free account

Satellos Bioscience Inc. (MSLE) vs Yarrow Bioscience, Inc (YARW)

Satellos Bioscience Inc. and Yarrow Bioscience, Inc are both Biotechnology companies. Satellos Bioscience Inc. and Yarrow Bioscience, Inc are of similar size ($152.6M and $147.2M). Satellos Bioscience Inc. has the higher net margin (0.00% vs −3,881.5%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Yarrow Bioscience, Inc leads on 6 and Satellos Bioscience Inc. on 5.

Valuation

Metric MSLE YARW Biotechnology median
P/E n/m n/m 10.60
P/S n/m 27.77 9.40
P/B 2.50 0.61 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 118.48 9.02
Earnings yield (27.50%) (138.76%) (32.88%)
Free cash flow yield (19.37%) (127.91%) (23.13%)

Profitability

Metric MSLE YARW Biotechnology median
Gross margin — 100.00% 68.51%
Operating margin 0.00% (4,134.44%) 0.00%
Net margin 0.00% (3,881.54%) 0.00%
Free cash flow margin 0.00% (3,513.07%) 0.00%
Return on equity (70.45%) (61.40%) (51.96%)
Return on assets (64.76%) (54.77%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric MSLE YARW Biotechnology median
Revenue growth (TTM) — 1.26% 6.76%
EPS growth (last fiscal year) 21.20% 32.26% 29.88%
Revenue growth, 5-year CAGR — (51.39%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric MSLE YARW Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 11.22 15.26 4.97
Net debt to EBITDA 1.05 0.95 1.01

Dividend

Metric MSLE YARW Biotechnology median
Dividend yield — 0.10% 0.41%
Payout ratio — — —

Size

Metric MSLE YARW Biotechnology median
Market cap 152.57m 147.23m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack